Cariprazine positive for bipolar patients - Forest, Richter

BUDAPEST, March 31 (Reuters) - Hungarian drug maker Gedeon Richter and its partner Forest Laboratoriess announced positive top-line results from a Phase IIb trial of antipsychotic drug Cariprazine in patients with bipolar depression, the companies said in a statement on Monday.